Search filters

List of works by Donald H Berry

Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia

scientific article published in May 2003

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

scientific article

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

scientific article

Adjuvant chemotherapy in older women with early-stage breast cancer

scientific article

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical T

scientific article published on 23 July 2020

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

scientific article

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

scientific article published on 12 January 2016

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

scientific article

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

scientific article published on 13 February 2020

Electrochemistry of Ruthenium Bis(imino)pyridine Compounds: Evidence for an ECE Mechanism and Isolation of Mono and Dicationic Complexes.

scientific article

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

scientific article

Evidence for ligand non-innocence in a formally ruthenium(I) hydride complex

scientific article published in March 2010

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

scientific article published in June 2004

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

scientific article published in March 2003

In Reply:

Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.

scientific article

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

article

Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer

scientific article published in September 2004

Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343

scientific article published on 20 May 2013

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial

scientific article published on 07 February 2019

Magnetism and EPR Studies of Binuclear Ruthenium Hydride Binuclear Species Bearing Redox-Active Ligands

scientific article published on 06 June 2018

Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.

scientific article published in May 2003

Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.

scientific article published on June 2008

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

article

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

article

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

scientific article published on 24 July 2019

Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al

scientific article published on 04 November 2013

Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes

scientific article

Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.

scientific article

Structure and reactivity of bis(silyl) dihydride complexes (PMe(3))(3)Ru(SiR(3))(2)(H)(2): model compounds and real intermediates in a dehydrogenative C-Si bond forming reaction

scientific article

Synthesis and reactivity of silyl ruthenium complexes: the importance of trans effects in C-H activation, Si-C bond formation, and dehydrogenative coupling of silanes

scientific article published on 01 July 2003

Synthesis and structure of ruthenium-silylene complexes: activation of Si-Cl bonds in N-heterocyclic silanes

scientific article published on 01 May 2006

Synthesis of tridentate 2,6-bis(imino)pyridyl ruthenium(II) complexes with N-heterocyclic carbene ligands: activation of imidazolium salts

scientific article published on 22 October 2014

Tandem beta-C-H activation/Si-H elimination reactions: stabilization of C-H activation products by beta-agostic Si-H interactions

scientific article published on 01 August 2003

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

scientific article published on 24 February 2015

The first optically active polygermanes: preferential screw sense helicity of enantiopure chiral-substituted aryl polygermanes and comparison with analogous polysilanes

scientific article

Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience

article

Paulina is supported by:

About Paulina

Help